New era for weight-loss drugs after US approves pill version of Wegovy

The US FDA has approved a pill version of the weight-loss drug Wegovy developed by Novo Nordisk, presenting a new option in the weight-loss market. This FDA approval makes Wegovy the first pill of its kind to gain regulatory approval for weight loss. Novo Nordisk stated the pill offers similar weight-loss benefits as the injectable form of the drug and provides a more convenient delivery method for users. Additionally, the drug joins similar medications like Ozempic in offering weight-loss benefits beyond their primary approval for treating Type 2 diabetes.